Module

Best of Hepatitis 2007: Top Findings in Viral Hepatitis

Source: Hepatitis Annual Update 2007

Best of Hepatitis 2007: Top Findings in Viral Hepatitis

Faculty:

Harvey Alter, MD

CREDIT INFORMATION

Release Date: August 06, 2007

Expiration Date: August 05, 2008

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.2 Nursing contact hours

Pharmacists: 1.2 contact hours (0.12 CEUs)

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize major findings in viral hepatitis from 2006 and early 2007
Discuss the broader perspective within which key developments in viral hepatitis should be viewed
Describe the impact of recent developments in hepatitis on disease management

Topics covered include:

Introduction
Hepatitis C Virus – Cell Culture Systems: JFH1 and Chimeras
Hepatitis C Virus – Cell Culture Systems: Genotype 1 and Human Fetal Hepatocyte Cell Culture Systems
HCV Receptors, Viral Attachment, and Entry
Neutralizing Antibodies Against HCV
HCV Persistence
Natural History of Hepatitis C
Treatment of Hepatitis C: Acute infection
Treatment of Hepatitis C: DEBIO-025
Treatment of HCV Patients With Advanced Fibrosis
HCV Vaccine Development
Models of Acute HBV Infection
Chronic Hepatitis B in Children
Hepatitis E Virus
Summary: Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.